TY - JOUR
T1 - Recommendations for the management of childhood juvenile idiopathic arthritis-type chronic anterior uveitis
AU - Smith, Justine R.
AU - Matthews, Janet M.
AU - Conrad, Diana
AU - Hall, Anthony J.
AU - Niederer, Rachael L.
AU - Singh-Grewal, Davinder
AU - Tay-Kearney, Mei Ling
AU - Wells, Jane M.
AU - Zagora, Sophia L.
AU - Australian and New Zealand Juvenile Idiopathic Arthritis-Uveitis Working Group
AU - Chang, John H.
AU - Cornish, Elisa
AU - Deva, Narme
AU - Dunlop, Anthony A. S.
AU - Fagan, Xavier
AU - Fraser-Bell, Samantha
AU - Greenwell, Timothy
AU - Guest, Stephen
AU - Hay-Smith, Graham
AU - Heydon, Peter G.
AU - Hooper, Claire Y.
AU - Lim, Lyndell
AU - Lin, Ming-Lee
AU - Richards, Josephine
AU - Sims, Jo
AU - Stawell, Richard
AU - Symes, Richard
AU - Troutbeck, Robyn
AU - Vaze, Anagha
AU - Wakefield, Denis
AU - Younan, Christine
AU - McCluskey, Peter J.
PY - 2021/1
Y1 - 2021/1
N2 - IMPORTANCE: Australian- and New Zealand-based, uveitis-specialized ophthalmologists have produced recommendations for the management of juvenile idiopathic arthritis (JIA)-type chronic anterior uveitis. BACKGROUND: Historically, the visual prognosis of JIA-type chronic anterior uveitis has been poor. New medical advances are likely to improve outcomes, but recently published guidelines are tailored for ophthalmic care in Europe and the United States. DESIGN: This work involved a consensus survey and a panel meeting. PARTICIPANTS: The Australian and New Zealand JIA-Uveitis Working Group (29 ophthalmologists) participated in the work. METHODS: The Delphi technique was used to achieve consensus. MAIN OUTCOME MEASURES: This work yielded consensus statements. RESULTS: The Working Group achieved consensus around 18 statements related to clinical evaluation, use of topical and regional corticosteroids, use of systemic corticosteroid and non-corticosteroid immunomodulatory drugs, and management of secondary cataract and glaucoma in childhood JIA-type uveitis. CONCLUSIONS AND RELEVANCE: Recommendations of the Australian and New Zealand JIA-Uveitis Working Group provide current and regionally applicable advice for managing chronic anterior uveitis in children with JIA.
AB - IMPORTANCE: Australian- and New Zealand-based, uveitis-specialized ophthalmologists have produced recommendations for the management of juvenile idiopathic arthritis (JIA)-type chronic anterior uveitis. BACKGROUND: Historically, the visual prognosis of JIA-type chronic anterior uveitis has been poor. New medical advances are likely to improve outcomes, but recently published guidelines are tailored for ophthalmic care in Europe and the United States. DESIGN: This work involved a consensus survey and a panel meeting. PARTICIPANTS: The Australian and New Zealand JIA-Uveitis Working Group (29 ophthalmologists) participated in the work. METHODS: The Delphi technique was used to achieve consensus. MAIN OUTCOME MEASURES: This work yielded consensus statements. RESULTS: The Working Group achieved consensus around 18 statements related to clinical evaluation, use of topical and regional corticosteroids, use of systemic corticosteroid and non-corticosteroid immunomodulatory drugs, and management of secondary cataract and glaucoma in childhood JIA-type uveitis. CONCLUSIONS AND RELEVANCE: Recommendations of the Australian and New Zealand JIA-Uveitis Working Group provide current and regionally applicable advice for managing chronic anterior uveitis in children with JIA.
KW - immunosuppression
KW - juvenile rheumatoid arthritis
KW - uveitis
UR - http://www.scopus.com/inward/record.url?scp=85100677650&partnerID=8YFLogxK
U2 - 10.1111/ceo.13856
DO - 10.1111/ceo.13856
M3 - Article
C2 - 33426782
AN - SCOPUS:85100677650
VL - 49
SP - 38
EP - 45
JO - Clinical and Experimental Ophthlamology
JF - Clinical and Experimental Ophthlamology
SN - 1442-9071
IS - 1
ER -